These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

140 related items for PubMed ID: 21845837

  • 1. [Mechanism of intravenous immunoglobulin therapy for severe hand-foot-mouth disease: a review].
    Cao R, Han J, Qin E, Qin C.
    Sheng Wu Gong Cheng Xue Bao; 2011 May; 27(5):712-6. PubMed ID: 21845837
    [Abstract] [Full Text] [Related]

  • 2. Generation of neutralizing monoclonal antibodies against Enterovirus 71 using synthetic peptides.
    Li X, Mao C, Ma S, Wang X, Sun Z, Yi Y, Guo M, Shen X, Sun L, Bi S.
    Biochem Biophys Res Commun; 2009 Dec 25; 390(4):1126-8. PubMed ID: 19799860
    [Abstract] [Full Text] [Related]

  • 3. Neutralization of five subgenotypes of Enterovirus 71 by Taiwanese human plasma and Taiwanese plasma derived intravenous immunoglobulin.
    Wu CY, Wang HC, Wang KT, Weng SC, Chang WH, Shih DY, Lo CF, Wang DY.
    Biologicals; 2013 May 25; 41(3):154-7. PubMed ID: 23515089
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Seroepidemiology of Enterovirus 71 infection prior to the 2011 season in children in Shanghai.
    Zeng M, El Khatib NF, Tu S, Ren P, Xu S, Zhu Q, Mo X, Pu D, Wang X, Altmeyer R.
    J Clin Virol; 2012 Apr 25; 53(4):285-9. PubMed ID: 22265829
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Recent Progress towards Novel EV71 Anti-Therapeutics and Vaccines.
    Ng Q, He F, Kwang J.
    Viruses; 2015 Dec 08; 7(12):6441-57. PubMed ID: 26670245
    [Abstract] [Full Text] [Related]

  • 9. Presence of high-titer neutralizing antibodies against enterovirus 71 in intravenous immunoglobulin manufactured from Chinese donors.
    Cao R, Han J, Deng Y, Yu M, Qin E, Qin C.
    Clin Infect Dis; 2010 Jan 01; 50(1):125-6. PubMed ID: 20001529
    [No Abstract] [Full Text] [Related]

  • 10. A bispecific broadly neutralizing antibody against enterovirus 71 and coxsackievirus A16 with therapeutic potential.
    Zhou B, Xu L, Zhu R, Tang J, Wu Y, Su R, Yin Z, Liu D, Jiang Y, Wen C, You M, Dai L, Lin Y, Chen Y, Yang H, An Z, Fan C, Cheng T, Luo W, Xia N.
    Antiviral Res; 2019 Jan 01; 161():28-35. PubMed ID: 30419253
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. EV71: an emerging infectious disease vaccine target in the Far East?
    Xu J, Qian Y, Wang S, Serrano JM, Li W, Huang Z, Lu S.
    Vaccine; 2010 Apr 30; 28(20):3516-21. PubMed ID: 20304038
    [Abstract] [Full Text] [Related]

  • 13. Efficacy, safety, and immunogenicity of an enterovirus 71 vaccine in China.
    Zhu F, Xu W, Xia J, Liang Z, Liu Y, Zhang X, Tan X, Wang L, Mao Q, Wu J, Hu Y, Ji T, Song L, Liang Q, Zhang B, Gao Q, Li J, Wang S, Hu Y, Gu S, Zhang J, Yao G, Gu J, Wang X, Zhou Y, Chen C, Zhang M, Cao M, Wang J, Wang H, Wang N.
    N Engl J Med; 2014 Feb 27; 370(9):818-28. PubMed ID: 24571754
    [Abstract] [Full Text] [Related]

  • 14. Induction of protective immune responses against EV71 in mice by baculovirus encoding a novel expression cassette for capsid protein VP1.
    Premanand B, Kiener TK, Meng T, Tan YR, Jia Q, Chow VT, Kwang J.
    Antiviral Res; 2012 Sep 27; 95(3):311-5. PubMed ID: 22691220
    [Abstract] [Full Text] [Related]

  • 15. Establishing China's national standards of antigen content and neutralizing antibody responses for evaluation of enterovirus 71 (EV71) vaccines.
    Liang Z, Mao Q, Gao Q, Li X, Dong C, Yu X, Yao X, Li F, Yin W, Li Q, Shen X, Wang J.
    Vaccine; 2011 Dec 06; 29(52):9668-74. PubMed ID: 22015395
    [Abstract] [Full Text] [Related]

  • 16. Estimation of the basic reproduction number of enterovirus 71 and coxsackievirus A16 in hand, foot, and mouth disease outbreaks.
    Ma E, Fung C, Yip SH, Wong C, Chuang SK, Tsang T.
    Pediatr Infect Dis J; 2011 Aug 06; 30(8):675-9. PubMed ID: 21326133
    [Abstract] [Full Text] [Related]

  • 17. Development of murine monoclonal antibodies with potent neutralization effects on enterovirus 71.
    Ku Z, Shi J, Liu Q, Huang Z.
    J Virol Methods; 2012 Dec 06; 186(1-2):193-7. PubMed ID: 22771741
    [Abstract] [Full Text] [Related]

  • 18. [The early diagnosis value of EV 71 IgM class antibodies in the hand, foot and mouth disease].
    Zhao J, Xu J, Chen WW, Li YL, Tang Y, Li J, Wang HB, Guo TS, Zhao M, Li BA, Mao YL.
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2011 Apr 06; 25(2):140-2. PubMed ID: 21863642
    [Abstract] [Full Text] [Related]

  • 19. Characterization of a monoclonal antibody against the 3D polymerase of enterovirus 71 and its use for the detection of human enterovirus A infection.
    Kiener TK, Lim XF, Jia Q, Meng T, Chow VT, Kwang J.
    J Virol Methods; 2012 Mar 06; 180(1-2):75-83. PubMed ID: 22226793
    [Abstract] [Full Text] [Related]

  • 20. [A pathogen analysis within 174 cases of hand-foot-mouth disease in the summer of 2009].
    Fu J, Cui XD, Sun CR, Wang TY.
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2011 Oct 06; 25(5):377-80. PubMed ID: 22338230
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.